表紙
市場調查報告書

生物醫藥品添加劑的全球市場 (2020∼2030年):三酸甘油酯、酯、甘露醇、山梨醇、蔗糖、右旋糖、澱粉、特殊添加劑等

Biopharmaceuticals Excipients Market 2020-2030: Triglycerides, Esters, Mannitol, Sorbitol, Sucrose, Dextrose, Starch, Specialty Biopharmaceutical Excipients & Others

出版商 Visiongain Ltd 商品編碼 940608
出版日期 內容資訊 英文 162 Pages
商品交期: 最快1-2個工作天內
價格
生物醫藥品添加劑的全球市場 (2020∼2030年):三酸甘油酯、酯、甘露醇、山梨醇、蔗糖、右旋糖、澱粉、特殊添加劑等 Biopharmaceuticals Excipients Market 2020-2030: Triglycerides, Esters, Mannitol, Sorbitol, Sucrose, Dextrose, Starch, Specialty Biopharmaceutical Excipients & Others
出版日期: 2020年04月15日內容資訊: 英文 162 Pages
簡介

生物醫藥品添加劑的市場預測將以12.2%的年複合成長率成長。

本報告提供全球生物醫藥品添加劑的市場調查,市場及產品概要,市場規模的變化、預測,各類型的明細,各地區、主要國家的詳細分析,市場的各種影響因素分析,主要企業簡介等資訊彙整。

第1章 報告概要

第2章 簡介

  • 產品
    • 可溶解劑、界面活性劑/乳化劑
    • 多元醇
    • 碳水化合物
    • 特殊添加劑、其他

第3章 全球生物醫藥品添加劑市場分析

  • PEST分析
  • 市場展望
  • 成長推動因素、阻礙要素
  • 市場機會
  • 市場課題
  • 主要地區、/國家
  • 運用方案
  • 全球成長率
  • SWOT分析

第4章 全球生物醫藥品添加劑市場預測

  • 市場預測
    • 可溶解劑、界面活性劑/乳化劑
    • 多元醇
    • 碳水化合物
    • 特殊添加劑、其他

第5章 主要國家市場預測

  • 地區概要
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 其他地區
  • 加拿大市場分析、預測
  • 美國市場分析、預測
  • 德國市場分析、預測
  • 法國市場分析、預測
  • 英國市場分析、預測
  • 義大利市場分析、預測
  • 西班牙市場分析、預測
  • 中國市場分析、預測
  • 澳洲市場分析、預測
  • 印度市場分析、預測
  • 印尼市場分析、預測
  • 韓國市場分析、預測
  • 中東市場分析、預測
  • 非洲市場分析、預測
  • 其他地區市場分析、預測

第6章 主要企業

  • Abitec Corp.
  • Signet Chemical Corporation Pvt. Ltd.
  • Roquette Freres SA
  • Sigachi Industries Pvt. Ltd.
  • Meggle AG
  • Colorcon, Inc.
  • DMV-Fonterra Excipients GmbH&Co. KG
  • Clariant AG
  • SPI Pharma Inc.
  • Pharmonix Biological Pvt. Ltd.

第7章 總論、建議

第8章 用語

第9章 相關報告

目錄
Product Code: PHA0734

The biopharmaceuticals excipients market is expected to grow at a CAGR of 12.2%.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 162-page report you will receive 85 charts- all unavailable elsewhere.

The 162-page report provides clear detailed insight into the biopharmaceuticals excipients market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Biopharmaceuticals excipients market forecasts to 2030

This report also breaks down the revenue forecast for the global pharmaceutical excipient market by product type (Solubilizers & Surfactants/Emulsifiers, Polyols, Carbohydrates, Speciality Biopharmaceutical Excipients)

Solubilizers & Surfactants/Emulsifiers:

  • Triglycerides
  • Esters
  • Others

This report also breaks down the revenue forecast for the biopharmaceuticals excipients market by Polyols:

  • Mannitol
  • Sorbitol
  • Others

This report also breaks down the revenue forecast for the biopharmaceuticals excipients market by carbohydrates:

  • Sucrose
  • Dextrose
  • Starch
  • Others

This report provides individual revenue forecasts to 2030 for these regional and national markets:

  • North America: US and Canada
  • Europe: UK, France, Germany, Spain, Italy, Rest of Europe
  • APAC: China, India, Australia, Indonesia, South Korea, Rest of APAC
  • MEA
  • RoW

Each region is further broken down by product type

Our study gives a SWOT & PEST Analysis

Our study discusses the selected leading companies that are the major players in the biopharmaceuticals excipients market:

  • ABITEC Corp
  • Signet Chemical Corporation
  • Roquette Freres SA
  • Sigachi Industries
  • MEGGLE AG
  • & Other Companies

Visiongain's study is intended for anyone requiring commercial analyses for the biopharmaceuticals excipients market. You find data, trends, and predictions.

Buy our report today Biopharmaceuticals Excipients Market 2020-2030 : Triglycerides, Esters, Mannitol, Sorbitol, Sucrose, Dextrose, Starch, Specialty Biopharmaceutical Excipients & Others.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1 Report Overview

  • 1.1 Global Biopharmaceuticals Excipients Market Overview
  • 1.2 Segmentation
  • 1.3 Market Drivers, Restraints and Opportunities
  • 1.4 Why You Should Read This Report
  • 1.5 How This Report Delivers
  • 1.6 Key Questions Answered by This Analytical Report Include:
  • 1.7 Methodology
    • 1.7.1 Secondary Research
    • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.8 Frequently Asked Questions (FAQ)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Introduction to the Biopharmaceuticals Excipients Market

  • 2.1 Biopharmaceutical Excipients Product
    • 2.1.1 Solubilizers & Surfactants/Emulsifiers
    • 2.1.2 Polyols
    • 2.1.3 Carbohydrates
    • 2.1.4 Specialty Biopharmaceutical Excipients/Others

3 Global Biopharmaceuticals Excipients Market Analysis

  • 3.1 PEST Analysis of the Biopharmaceuticals Excipients Market
  • 3.2 Market Outlook
  • 3.3 Drivers & Restraints
    • 3.3.1 Growth in the biopharmaceutical industry
    • 3.3.2 Increasing burden of chronic disease
  • 3.4 Market Opportunity
    • 3.4.1 Advances in bioprocessing and biopharmaceutical industry, such as the rise in outsourcing trend
  • 3.5 Market Challenges
    • 3.5.1 Regulatory environment
    • 3.5.2 Pricing of medicines
  • 3.6 Dominant Region/Country
  • 3.7 Biopharmaceuticals Excipients Overall Operating Scenario
  • 3.8 Overall Growth Rate, Globally
  • 3.9 SWOT Analysis
    • 3.9.1 Strengths
    • 3.9.2 Weaknesses
    • 3.9.3 Opportunities
    • 3.9.4 Threats

4 Global Biopharmaceuticals Excipients Market 2020-2030

  • 4.1 Global Biopharmaceutical Excipients Product Market 2020-2030
    • 4.1.1 Global Solubilizers & Surfactants/Emulsifiers Market 2020-2030
    • 4.1.2 Global Polyols Market 2020-2030
    • 4.1.3 Global Carbohydrates Market 2020-2030
    • 4.1.4 Global Specialty Biopharmaceutical Excipients/Others Market 2020-2030

5 The Leading National Biopharmaceuticals Excipients Market Forecasts 2020-2030

  • 5.1 Regional Overview
    • 5.1.1 North America
    • 5.1.2 Europe
    • 5.1.3 Asia-Pacific
    • 5.1.4 Middle East & Africa
    • 5.1.5 Rest of the World
    • 5.1.6 Leading Countries/ Regions by Biopharmaceuticals Excipients Market
  • 5.2 Canada Biopharmaceuticals Excipients Market 2020-2030
    • 5.2.1 Canada Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
    • 5.2.2 Canada Biopharmaceuticals Excipients Market Analysis
  • 5.3 U.S. Biopharmaceuticals Excipients Market 2020-2030
    • 5.3.1 U.S. Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
    • 5.3.2 U.S. Biopharmaceuticals Excipients Market Analysis
  • 5.4 Germany Biopharmaceuticals Excipients Market 2020-2030
    • 5.4.1 Germany Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
    • 5.4.2 Germany Biopharmaceuticals Excipients Market Analysis
  • 5.5 France Biopharmaceuticals Excipients Market 2020-2030
    • 5.5.1 France Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
    • 5.5.2 France Biopharmaceuticals Excipients Market Analysis
  • 5.6 U.K. Biopharmaceuticals Excipients Market 2020-2030
    • 5.6.1 U.K. Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
    • 5.6.2 U.K. Biopharmaceuticals Excipients Market Analysis
  • 5.7 Italy Biopharmaceuticals Excipients Market 2020-2030
    • 5.7.1 Italy Biopharmaceuticals Excipients Submarket, By Solubilizers & Surfactants/Emulsifiers Type Forecast 2020-2030
    • 5.7.2 Italy Biopharmaceuticals Excipients Market Analysis
  • 5.8 Spain Biopharmaceuticals Excipients Market 2020-2030
    • 5.8.1 Spain Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
    • 5.8.2 Spain Biopharmaceuticals Excipients Market Analysis
  • 5.9 China Biopharmaceuticals Excipients Market 2020-2030
    • 5.9.1 China Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
    • 5.9.2 China Biopharmaceuticals Excipients Market Analysis
  • 5.10 Australia Biopharmaceuticals Excipients Market 2020-2030
    • 5.10.1 Australia Biopharmaceuticals Excipients Submarket, By Solubilizers & Surfactants/Emulsifiers Type Forecast 2020-2030
    • 5.10.2 Australia Biopharmaceuticals Excipients Market Analysis
  • 5.11 India Biopharmaceuticals Excipients Market 2020-2030
    • 5.11.1 India Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
    • 5.11.2 India Biopharmaceuticals Excipients Market Analysis
  • 5.12 Indonesia Biopharmaceuticals Excipients Market 2020-2030
    • 5.12.1 Indonesia Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
    • 5.12.2 Indonesia Biopharmaceuticals Excipients Market Analysis
  • 5.13 South Korea Biopharmaceuticals Excipients Market 2020-2030
    • 5.13.1 South Korea Biopharmaceuticals Excipients Submarket, By Solubilizers & Surfactants/Emulsifiers Type Forecast 2020-2030
    • 5.13.2 South Korea Biopharmaceuticals Excipients Market Analysis
  • 5.14 Rest of Asia Biopharmaceuticals Excipients Market 2020-2030
    • 5.14.1 Rest of Asia Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
    • 5.14.2 Rest of Asia Biopharmaceuticals Excipients Market Analysis
  • 5.15 Middle East Biopharmaceuticals Excipients Market 2020-2030
    • 5.15.1 Middle East Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
    • 5.15.2 Middle East Biopharmaceuticals Excipients Market Analysis
  • 5.16 Africa Biopharmaceuticals Excipients Market 2020-2030
    • 5.16.1 Africa Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
    • 5.16.2 Africa Biopharmaceuticals Excipients Market Analysis
  • 5.17 Rest of the World Biopharmaceuticals Excipients Market 2020-2030
    • 5.17.1 Rest of the World Biopharmaceuticals Excipients Submarket, By Product Forecast 2020-2030
    • 5.17.2 Rest of the World Biopharmaceuticals Excipients Market Analysis

6 The Leading Companies in the Biopharmaceuticals Excipients Market

  • 6.1 Abitec Corp.
    • 6.1.1 Abitec Corp. Overview
    • 6.1.2 Abitec Corp. Product Portfolio
    • 6.1.3 Abitec Corp. SWOT Analysis
    • 6.1.4 Abitec Corp. Key Development
  • 6.2 Signet Chemical Corporation Pvt. Ltd.
    • 6.2.1 Signet Chemical Corporation Overview
    • 6.2.2 Signet Chemical Corporation SWOT Analysis
    • 6.2.3 Signet Chemical Corporation Recent Development
  • 6.3 Roquette Freres SA
    • 6.3.1 Roquette Freres SA Overview
    • 6.3.2 Roquette Freres SA SWOT Analysis
    • 6.3.3 Roquette Freres SA Recent Development
  • 6.4 Sigachi Industries Pvt. Ltd.
    • 6.4.1 Sigachi Industries Overview
    • 6.4.2 Sigachi Industries Product Portfolio
    • 6.4.3 Sigachi Industries SWOT Analysis
  • 6.5 Meggle AG
    • 6.5.1 Meggle Overview
    • 6.5.2 Meggle Product Offering
    • 6.5.3 Meggle AG SWOT Analysis
    • 6.5.4 Meggle Recent Development
  • 6.6 Colorcon, Inc.
    • 6.6.1 Colorcon Overview
    • 6.6.2 Colorcon Product Portfolio
    • 6.6.3 Colorcon SWOT Analysis
    • 6.6.4 Colorcon Recent Development
  • 6.7 DMV-Fonterra Excipients GmbH & Co. KG
    • 6.7.1 DMV-Fonterra Excipients Overview
    • 6.7.2 DMV-Fonterra Excipients Product Offerings
    • 6.7.3 DMV-Fonterra Excipients SWOT Analysis
    • 6.7.4 DMV-Fonterra Excipients Recent Development
  • 6.8 Clariant AG
    • 6.8.1 Clariant Overview
    • 6.8.2 Clariant Product Offering
    • 6.8.3 Clariant SWOT Analysis
    • 6.8.4 Clariant Recent Development
  • 6.9 SPI Pharma Inc.
    • 6.9.1 SPI Overview
    • 6.9.2 SPI Product Offerings
    • 6.9.3 SPI SWOT Analysis
    • 6.9.4 SPI Recent Development
  • 6.10 Pharmonix Biological Pvt. Ltd.
    • 6.10.1 Pharmonix Overview
    • 6.10.2 Pharmonix Product Offering
    • 6.10.3 Pharmonix SWOT Analysis

7 Conclusions and Recommendations

  • 7.1 Global Biopharmaceuticals Excipients Market Outlook
  • 7.2 Recommendations

8 Glossary

9 Associated Visiongain Reports

  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • 10 Appendix B
  • 10.1 Visiongain report evaluation form

List of Tables

  • Table 2.1 Companies Providing Solubilizers and Surfactants Products, Features and Applications
  • Table 3.1 Licensed Biological Products, 2019
  • Table 4.1 Global Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
  • Table 4.2 Global Biopharmaceuticals Excipients Market Forecast by Solubilizers & Surfactants/Emulsifiers 2020-2030 (US$m, AGR %, Cumulative)
  • Table 4.3 Global Biopharmaceuticals Excipients Market Forecast by Polyols 2020-2030 (US$m, AGR %, Cumulative)
  • Table 4.4 Global Biopharmaceuticals Excipients Market Forecast by Carbohydrates 2020- 2030 (US$m, AGR %, Cumulative)
  • Table 4.5 Global Biopharmaceuticals Excipients Market Forecast by Specialty Biopharmaceutical Excipients 2020-2030 (US$m, AGR %, Cumulative)
  • Table 5.1 North America Biopharmaceutical Excipient Markets Forecast by Country 2020- 2030 (US$m, AGR %, Cumulative)
  • Table 5.2 Europe Biopharmaceutical Excipient Markets Forecast by Country 2020-2030 (US$m, AGR %, Cumulative)
  • Table 5.3 Asia-Pacific Biopharmaceutical Excipient Markets Forecast by Country 2020-2030 (US$m, AGR %, Cumulative)
  • Table 5.4 Rest of World Biopharmaceutical Excipient Markets Forecast by Country 2020-2030 (US$m, AGR %, Cumulative)
  • Table 5.5 Canada Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
  • Table 5.6 US Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
  • Table 5.7 Germany Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
  • Table 5.8 France Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
  • Table 5.9 UK Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
  • Table 5.10 Italy Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
  • Table 5.11 Spain Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
  • Table 5.12 China Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
  • Table 5.13 Australia Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
  • Table 5.14 India Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
  • Table 5.15 Indonesia Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
  • Table 5.16 South Korea Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
  • Table 5.17 Rest of Asia Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
  • Table 5.18 Middle East Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
  • Table 5.19 Africa Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
  • Table 5.20 Rest of the World Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
  • Table 6.1 ABITEC CORP. 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
  • Table 6.2 Abitec Corp. Product Portfolio, 2020
  • Table 6.3 Signet Chemical Corporation Pvt. Ltd. 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
  • Table 6.4 Roquette Freres SA 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
  • Table 6.5 Roquette Freres SA Product Portfolio 2020
  • Table 6.6 Sigachi Industries Pvt. Ltd. 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
  • Table 6.7 Sigachi Industries Pvt. Ltd. Product Portfolio 2020
  • Table 6.8 Meggle AG 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
  • Table 6.9 Meggle AG Product Portfolio 2020
  • Table 6.10 Colorcon, Inc. 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
  • Table 6.11 Colorcon, Inc. Product Portfolio 2020
  • Table 6.12 DMV-Fonterra Excipients GmbH & Co. KG 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
  • Table 6.13 DMV-Fonterra Excipients GmbH & Co. KG Product Portfolio 2020
  • Table 6.14 Clariant AG 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
  • Table 6.15 Clariant AG Product Portfolio 2020
  • Table 6.16 SPI Pharma Inc. 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
  • Table 6.17 SPI Product Portfolio 2020
  • Table 6.18 Pharmonix Biological Pvt. Ltd. 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
  • Table 6.19 Pharmonix Product Portfolio 2020

List of Figures

  • Figure 1.1 Global Biopharmaceutical Excipient Market Forecast 2020-2030 (US$ m, AGR %)
  • Figure 1.2 Global Biopharmaceutical Excipients Market Segmentation
  • Figure 3.1 US Healthcare Expenditure, 1970-2017 (Billion)
  • Figure 3.2 Benefits provided by business collaborations
  • Figure 4.1 Global Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
  • Figure 4.2 Global Biopharmaceuticals Excipients Market Forecast by Solubilizers & Surfactants/Emulsifiers 2020-2030 (US$m, Global AGR %)
  • Figure 4.3 Global Biopharmaceuticals Excipients Market Forecast by Triglycerides 2020-2030 (US$m, Global AGR %)
  • Figure 4.4 Global Biopharmaceuticals Excipients Market Forecast by Esters 2020-2030 (US$m, Global AGR %)
  • Figure 4.5 Global Biopharmaceuticals Excipients Market Forecast by Others 2020-2030 (US$m, Global AGR %)
  • Figure 4.6 Global Biopharmaceuticals Excipients Market Forecast by Polyols 2020-2030 (US$m, Global AGR %)
  • Figure 4.7 Global Biopharmaceuticals Excipients Market Forecast by Mannitol 2020-2030 (US$m, Global AGR %)
  • Figure 4.8 Global Biopharmaceuticals Excipients Market Forecast by Sorbitol 2020-2030 (US$m, Global AGR %)
  • Figure 4.9 Global Biopharmaceuticals Excipients Market Forecast by Others 2020-2030 (US$m, Global AGR %)
  • Figure 4.10 Global Biopharmaceuticals Excipients Market Forecast by Carbohydrates 2020-2030 (US$m, Global AGR %)
  • Figure 4.11 Global Biopharmaceuticals Excipients Market Forecast by Sucrose 2020-2030 (US$m, Global AGR %)
  • Figure 4.12 Global Biopharmaceuticals Excipients Market Forecast by Dextrose 2020-2030 (US$m, Global AGR %)
  • Figure 4.13 Global Biopharmaceuticals Excipients Market Forecast by Starch 2020-2030 (US$m, Global AGR %)
  • Figure 4.14 Global Biopharmaceuticals Excipients Market Forecast by Others 2020-2030 (US$m, Global AGR %)
  • Figure 4.15 Global Biopharmaceuticals Excipients Market Forecast by Specialty Biopharmaceutical Excipients 2020-2030 (US$m, Global AGR %)
  • Figure 5.1 North America Biopharmaceutical Excipient Markets Forecast by Country 2020-2030 (US$m, AGR %, Cumulative)
  • Figure 5.2 Europe Biopharmaceutical Excipient Markets Forecast by Country 2020-2030 (US$m, AGR %, Cumulative)
  • Figure 5.3 Asia Pacific Biopharmaceutical Excipient Markets Forecast by Country 2020-2030 (US$m, AGR %, Cumulative)
  • Figure 5.4 Rest of World Biopharmaceutical Excipient Markets Forecast by Country 2020-2030 (US$m, AGR %, Cumulative)
  • Figure 5.5 Canada Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
  • Figure 5.6 US Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
  • Figure 5.7 Germany Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
  • Figure 5.8 France Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
  • Figure 5.9 UK Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
  • Figure 5.10 Italy Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
  • Figure 5.11 Spain Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
  • Figure 5.12 China Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
  • Figure 5.13 Australia Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
  • Figure 5.14 India Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
  • Figure 5.15 Indonesia Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
  • Figure 5.16 South Korea Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
  • Figure 5.17 Rest of Asia Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
  • Figure 5.18 Middle East Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
  • Figure 5.19 Africa Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
  • Figure 5.20 Rest of the World Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)

List of Companies and Organizations Mentioned in the Report:

  • ABITEC Corp
  • Aventis Behring L.L.C
  • BASF
  • BASF SE
  • Bio Products Laboratory
  • Biogen
  • Cambrex
  • Captisol
  • Celltrion
  • Clariant AG
  • Colorcon
  • Coriolis Pharma
  • CSL Behring GmbH
  • DMV-Fonterra Excipients GmbH & Co. KG
  • EMA
  • Emergent BioDefense Operations Lansing, Inc
  • Evonik Industries AG
  • Gattefosse
  • Genetics Institute, Inc
  • Grifols Biologicals, Inc
  • GTC Biotherapeutics, Inc
  • International Conference of Drug Regulatory Authorities (ICDRA)
  • International Council for Harmonization (ICH)
  • Kedrion Biopharmaceuticals, SpA
  • MEGGLE AG
  • Merck
  • Novo Nordisk
  • Octapharma USA, Inc
  • Pan American Network for Drug Regulatory Harmonization (PANDRH)
  • Pharmaceutical Inspection Cooperation Scheme (PIC/S)
  • Pharmaceutical Research and Manufacturers of America (PhRMA)
  • Pharmonix Biological
  • Roquette Freres SA
  • Samsung BioLogics
  • Sigachi Industries
  • Signet Chemical Corporation
  • SPI Pharma Inc.
  • Talecris Biotherapeutics, Inc.
  • the Center for Drug Evaluation and Research (CDER)
  • The Lubrizol Corporation